Kbio Holdings Limited

Youngjun Oh

Barry Bratcher

Joshua D Morton

Steven D Hume

Greg Pogue

Nick Partain

John W Shepherd

Hugh A Haydon

Leigh Burden

Carrie A Simpson

Michael H Pauly

Disclosed herein are methods of forming compounds and exemplary compounds in the nature of a conjugated compound, which in some embodiments comprises an antigen and virus particle mixed in a conjugation reaction to form a conjugate mixture, such that the conditions and steps of forming these products allow for use of the conjugate mixture as a vaccine, including but not limited to use as a vaccine against various pathogens including for treatment of diseases caused by novel coronaviruses (including SARS-COV 2).

Vaccines formed by virus and antigen conjugation

Disclosed herein are methods of forming compounds and exemplary stable compounds in the nature of a conjugated compound at refrigerated or room temperature, which in some embodiments comprises an antigen and virus particle mixed in a conjugation reaction to form a conjugate mixture, such that the conditions and steps of forming these products allow for use of the conjugate mixture as a vaccine, including but not limited to use as a vaccine against various pathogens including for treatment of diseases caused by novel coronaviruses (including SARS-COV 2).

Growing community of inventors

Owensboro, KY, United States of America

Youngjun Oh